Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again
Feb 28, 2023 15:03 HKT | |
|
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 17:30 HKT |  |
|
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Feb 23, 2023 10:18 HKT | |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Feb 22, 2023 18:48 HKT |  |
|
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Feb 22, 2023 14:30 HKT | |
|
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
Feb 16, 2023 17:09 HKT |  |
|
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital
Feb 15, 2023 18:58 HKT | |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
Feb 15, 2023 09:00 HKT |  |
|
ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups
Feb 14, 2023 17:00 HKT |  |
|
Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results
Feb 14, 2023 10:57 HKT |  |
|
EC Healthcare Announced Strategic Alliance with Prudential
Feb 13, 2023 19:09 HKT |  |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Feb 10, 2023 21:06 HKT | |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific
Feb 10, 2023 19:00 HKT | |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT | |
|
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202
Feb 03, 2023 10:01 HKT | |
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 01, 2023 10:00 HKT | |
|
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively
Jan 30, 2023 11:38 HKT | |
|
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
Jan 26, 2023 12:16 HKT |  |
|
EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY
Jan 20, 2023 19:31 HKT | |
|
BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK
Jan 17, 2023 14:25 HKT | |
|